| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027692 |
| Receipt No. | R000031721 |
| Scientific Title | Examination of the influence for cognitive function of aromatherapy using the essential oil which was extracted from Abies sachalinensis. |
| Date of disclosure of the study information | 2017/06/09 |
| Last modified on | 2019/03/20 (Ver. 5) |
| Basic information | ||
| Public title | Examination of the influence for cognitive function of aromatherapy using the essential oil which was extracted from Abies sachalinensis. | |
| Acronym | Examination of the aromatherapy using the essential oil which was extracted from Abies sachalinensis | |
| Scientific Title | Examination of the influence for cognitive function of aromatherapy using the essential oil which was extracted from Abies sachalinensis. | |
| Scientific Title:Acronym | Examination of the aromatherapy using the essential oil which was extracted from Abies sachalinensis | |
| Region |
|
|
| Condition | ||||
| Condition | Alzheimer's disease, mild cognitive impairment | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | The aim of this study is to investigate whether aromatherapy using the essential oil which was extracted from Abies sachalinensis affects for cognitive function in Alzheimer's disease |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The results of Touch Panel-type Dementia Assessment Scale (TDAS) after four weeks |
| Key secondary outcomes | The results of Odor Stick Identification Test for the Japanese, questionnaire and blood tests after four weeks |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Dose comparison |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | In before and after using aromatherapy using the 100% essential oil which was extracted from Abies sachalinensis, we carry out test of cognitive function, olfactometry, questionnaires and blood tests. Subjects carry out the aromatherapy for two hours in the morning and two hours at night, and continue for four weeks | |
| Interventions/Control_2 | In before and after using aromatherapy using the 30% essential oil which was extracted from Abies sachalinensis, we carry out test of cognitive function, olfactometry, questionnaires and blood tests. Subjects carry out the aromatherapy for two hours in the morning and two hours at night, and continue for four weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Subjects who are more than 40 years old at the time of registration
2) Alzheimer's disease patients who fulfill of the DSM-5 and NINCDS-ADRDA criteria, or mild cognitive impairment patients who fulfill of the Petersen criteria. 3) The consent from proxies is necessary. 4) If the patient use antidementia medicine, it is necessary that cognitive function is stable |
|||
| Key exclusion criteria | 1) Subjects who have a serious allergic disease
2) Subjects who are diagnosed olfactory disturbance 3) Subjects who have a serious heart disease 4) Subjects who have the past of epilepsy 5) Subjects who are conducting other aromatherapy during the intervention period 6) Pregnant women 7) Subjects who are assessed by the principal investigator due to other reasons |
|||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | School of Health Science, Faculty of Medicine, Tottori University | ||||||
| Division name | Department of Biological Regulation | ||||||
| Zip code | |||||||
| Address | 86 Nishicho, Yonago, Tottori, Japan | ||||||
| TEL | 0859-38-6354 | ||||||
| kurakami@med.tottori-u.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | School of Health Science, Faculty of Medicine, Tottori University | ||||||
| Division name | Department of Biological Regulation | ||||||
| Zip code | |||||||
| Address | 86 Nishicho, Yonago, Tottori, Japan | ||||||
| TEL | 0859-38-6358 | ||||||
| Homepage URL | |||||||
| kouzuki@med.tottori-u.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Biological Regulation, School of Health Science, Faculty of Medicine, Tottori University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Aroma Laboratory Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031721 |